Binding and interactions of a novel potent indole-5-carboxamide MAO-B inhibitor

Comptes Rendus de L'Academie Bulgare des Sciences

Volumn 67, Issue 7, 2014, Pages 937-942

  Tzvetkov, Nikolay T ^a   Pajeva, Ilza K ^b  

^a UNIVERSITY OF BONN   (Germany)

^b INSTITUTE OF BIOPHYSICS AND BIOMEDICAL ENGINEERING   (Bulgaria)

Author keywords

Alzheimer's disease; Drug receptor interactions; MAO B inhibitors; Parkinson's disease

Indexed keywords

EID: 84905110804     PISSN: 13101331     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Shih J. C., K. Chen, M. J. Ridd. Ann. Rev. Neurosci., 22, 1999, 197-217.
2. Malek N. M., D. G. Grosset. J. Exp. Pharmacol., 4, 2012, 85-90.
3. Castagnoli N. Jr., J. P. Petzer, S. Steyn, K. Castagnoli, J.-F. Chen, M. A. Schwarzschild, C. J. Van Der Schyf. Neurology, 61, 2003, No 11, Suppl. 6, S62-S68.
4. Jankovic J., W. Poewe. Curr. Opin. Neurol., 25, 2012, No 4, 433-447.
5. Dunkel P., C. L. Chai, B. Sperlágh, P. B. Huleatt, P. Mátyus. Expert Opin. Investig. Drugs, 21, 2012, No 9, 1267-1308.
6. Binda C., F. Hubálek, M. Li, Y. Herzig, J. Sterling, D. E. Edmondson, A. Mattevi. J. Med. Chem., 47, 2004, No 7, 1767-1774.
7. Louis H. A. P, J. P. Petzer, S. F. Malan. Eur. J. Med. Chem., 45, 2010, No 10, 4458-4466.
8. Binda C., M. Aldeco, W. J. Geldenhuys, M. Tortorici, A. Mattevi, D. E. Edmondson. Med. Chem. Lett., 3, 2012, No 1, 39-42.
9. Binda C., J. Wang, L. Pisani, C. Caccia, A. Carotti, P. Salvati, D. E. Edmondson, A. Mattevi. J. Med. Chem., 50, 2007, No 23, 5848-5852.
10. Tzvetkov N. T., S. Hinz, P. Küppers, M. Gastreich, C. E. Müller. J. Med. Chem., 2014, accepted for publication.
11. Molecular Operating Environment (MOE), 2013.08; Chemical Computing Group Inc., 1010 Sherbooke St. West, Suite #910, Monreal, QC, Canada, H3A 2R7, 2010.
12. Protein Data Bank, http://www.rscb.org/pdb.